一次医療における遠隔医療ツールを用いた皮膚腫瘍の早期発見 (MEL)
プライマリケアにおける遠隔医療ツールを用いた皮膚腫瘍の早期発見
The project is a national, prospective, multicenter, single-arm interventional pilot of screening skin tumors in the Czech Republic.
The primary aim of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of skin tumors by using a telemedicine tools and setting up and testing new methods and implementation into the system of social health care.
調査の概要
詳細な説明
The project is a national, prospective, multicenter, single-arm interventional pilot project for skin tumors screening involving 18 general practitioners and 6 dermatology centers in the Czech Republic.
The main objective of the project is the early detection of skin tumors by general practitioners, increasing the efficiency of healthcare, and methodically preparing, implementing, and evaluating the pilot project. The project aims to verify the suitability of the proposed early detection procedure for skin tumors, as well as to establish and test new methods and integrate them into the healthcare system.
As part of the project, the procedure will be tested on a sample of approximately 1,440 individuals, which may help validate the use of telemedicine tools in healthcare. A methodology for the use of telemedicine tools will be developed, along with a framework for collaboration between general practitioners and affiliated dermatologists. Systemic changes will be proposed to enhance the efficiency of the screening process.
The project is supported by the European Social Fund (Operational Programme Employment Plus) and the state budget of the Czech Republic. It is registered with the Ministry of Labour and Social Affairs of the Czech Republic under ID: CZ.03.02.02/00/22_005/0002008.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Dagmar Obšilová, Msc
- 電話番号:+420606429382
- メール:dagmar.obsilova@uzis.cz
研究連絡先のバックアップ
- 名前:Lucie Mandelova, Ph.D.
- 電話番号:+420 770190 828
- メール:lucie.mandelova@uzis.cz
研究場所
-
-
-
Brno、チェコ
- まだ募集していません
- St. Anne's University Hospital Brno
-
コンタクト:
- Hana Jedličková, prof.
- メール:hjedlic@medmuni.cz
-
Olomouc、チェコ
- 募集
- Olomouc University Hospital
-
コンタクト:
- Zdeněk Drlík, MD
- メール:zdenek.drlik@fnol.cz
-
Pilsen、チェコ
- まだ募集していません
- University Hospital Pilsen
-
コンタクト:
- Jan Říčař, MD, Ph.D.
- メール:ricarj@fnplzen.cz
-
Prague、チェコ
- 募集
- Bulovka University Hospital
-
コンタクト:
- Filip Rob, Assoc. Prof.
- メール:filip.rob@bulovka.cz
-
Prague、チェコ
- まだ募集していません
- University hospital Kralovske Vinohrady
-
コンタクト:
- Petr Arenberger, prof.
- メール:petr.arenberger@lf3.cuni.cz
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- at least 1 suspected lession
- phototype I or phototype II
Exclusion Criteria:
- skin lession examination by dermatologist in last 12 months
- unsigned consent to participate in the project and consent to the processing of personal data
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Adults with suspected skin lession
Pilot screening will be conducted in general practitioners' offices, where physicians will be trained to examine skin lesions using magnifying devices (dermatoscopes) and advanced telemedicine software, enabling faster diagnostics of suspicious findings. Patients with high-risk lesions will be referred to specialized dermatology centers. |
The diagnostic management of enrolled patients will be guided by standardized procedures carried out in general practitioners' offices. Physicians will be trained to identify suspicious skin lesions, capture high-resolution images using dermatoscopes, and transfer the data into advanced telemedicine software. The platform, supported by AI-driven algorithms, enables precise risk stratification of lesions and facilitates remote consultation with collaborating dermatologists. Patients with high-risk lesions will be referred to specialized dermatology centers for further examination and intervention. In cases where excision of a lesion is performed, histopathological assessment will be conducted, and results will be systematically recorded within the dedicated telemedicine platform, ensuring secure and efficient information exchange between dermatologists and general practitioners. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Potential malignancies
時間枠:From enrollment to the end of examination - baseline.
|
Proportion of individuals with a potential presence of malignancy (detected through the telemedicine tool). |
From enrollment to the end of examination - baseline.
|
|
Confirmed malignancies
時間枠:From enrollment to the end of diagnosis at 3 months.
|
Proportion of individuals with confirmed potential malignancy by a dermatologist. |
From enrollment to the end of diagnosis at 3 months.
|
|
Confirmed malignancies by histology
時間枠:From enrollment to the end of diagnosis at 6 months.
|
Proportion of individuals in whom the diagnosis of malignancy was confirmed histologically. |
From enrollment to the end of diagnosis at 6 months.
|
協力者と研究者
捜査官
- スタディディレクター:Petr Arenberger, prof.、Hospital university Kralovske Vinohrady
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- UZIS 2025/6
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。